Related Experiment Videos
Serum CC-10 in inflammatory lung diseases.
Qing Ye1, Masaki Fujita, Hiroshi Ouchi
1Research Institute for Diseases of the Chest, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan.
Respiration; International Review of Thoracic Diseases
|October 7, 2004
Summary
Clara cell secretory protein (CC-10) levels vary in different lung diseases. Lower CC-10 may indicate asthma severity, while higher levels are seen in idiopathic interstitial pneumonia.
Area of Science:
- Pulmonary Medicine
- Biochemistry
Background:
- Clara cell secretory protein (CC-10) is implicated in lung disease, but its exact function is not fully understood.
- Investigating CC-10's role is crucial for understanding inflammatory lung conditions.
Purpose of the Study:
- To determine the role of CC-10 in various inflammatory lung diseases by measuring its protein levels.
- To explore the relationship between CC-10 concentrations and disease severity.
Main Methods:
- Collected serum and bronchoalveolar lavage (BAL) fluid from patients with asthma, COPD, sarcoidosis, IIP, CEP, pneumonia, and lung cancer.
- Measured serum CC-10 concentrations using ELISA and performed immunohistochemistry on lung biopsy samples.
- Analyzed the correlation between CC-10 levels and disease characteristics.
Main Results:
- CC-10 levels were elevated in idiopathic interstitial pneumonia (IIP) and decreased in bronchial asthma and chronic eosinophilic pneumonia (CEP).
- Immunohistochemistry showed abnormal CC-10 expression in fibrotic areas of IIP lung tissue.
- Serum CC-10 correlated with FEV(1)/FVC in asthma patients but not with severity in IIP, COPD, or sarcoidosis.
Conclusions:
- CC-10 levels show distinct patterns in different lung diseases.
- Serum CC-10 may serve as a potential biomarker for assessing bronchial asthma severity.